AAAAAA

   
Results: 1-16 |
Results: 16

Authors: Hahm, HA Dunn, VR Butash, KA Deveraux, WL Woster, PM Casero, RA Davidson, NE
Citation: Ha. Hahm et al., Combination of standard cytotoxic agents with polyamine analogues in the treatment of breast cancer cell lines, CLIN CANC R, 7(2), 2001, pp. 391-399

Authors: Zou, Y Wu, ZQ Sirisoma, N Woster, PM Casero, RA Weiss, LM Rattendi, D Lane, S Bacchi, CJ
Citation: Y. Zou et al., Novel alkylpolyamine analogues that possess both antitrypanosomal and antimicrosporidial activity, BIOORG MED, 11(12), 2001, pp. 1613-1617

Authors: Wang, YL Devereux, W Woster, PM Casero, RA
Citation: Yl. Wang et al., Cloning and characterization of the mouse polyamine-modulated factor-1 (mPMF-1) gene: an alternatively spliced homologue of the human transcription factor, BIOCHEM J, 359, 2001, pp. 387-392

Authors: Woster, PM
Citation: Pm. Woster, Chapter 10. New therapies for parasitic infection, ANNU REP M, 36, 2001, pp. 99-108

Authors: Casero, RA Woster, PM
Citation: Ra. Casero et Pm. Woster, Terminally alkylated polyamine analogues as chemotherapeutic agents, J MED CHEM, 44(1), 2001, pp. 1-26

Authors: Wang, YL Devereux, W Woster, PM Stewart, TM Hacker, A Casero, RA
Citation: Yl. Wang et al., Cloning and characterization of a human polyamine oxidase that is inducible by polyamine analogue exposure, CANCER RES, 61(14), 2001, pp. 5370-5373

Authors: McCloskey, DE Woster, PM Casero, RA Davidson, NE
Citation: De. Mccloskey et al., Effects of the polyamine analogues N-1-Ethyl-N-11-((cyclopropyl)methyl)-4,8-diazaundecane and N-1-ethyl-N-11-((cycloheptyl)methyl)-4,8-diazaundecane in human prostate cancer cells, CLIN CANC R, 6(1), 2000, pp. 17-23

Authors: Iyer, R Wu, ZQ Woster, PM Delcour, AH
Citation: R. Iyer et al., Molecular basis for the polyamine-OmpF porin interactions: Inhibitor and mutant studies, J MOL BIOL, 297(4), 2000, pp. 933-945

Authors: Reilly, TP Lash, LH Doll, MA Hein, DW Woster, PM Svensson, CK
Citation: Tp. Reilly et al., A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug Reactions, J INVES DER, 114(6), 2000, pp. 1164-1173

Authors: Nairn, LM Lindsay, GS Woster, PM Wallace, HM
Citation: Lm. Nairn et al., Cytotoxicity of novel unsymmetrically substituted inhibitors of polyamine biosynthesis in human cancer cells. (vol 182, pg 209, 2000), J CELL PHYS, 183(1), 2000, pp. 143-143

Authors: Nairn, LM Lindsay, GS Woster, PM Wallace, HM
Citation: Lm. Nairn et al., Cytotoxicity of novel unsymmetrically substituted inhibitors of polyamine biosynthesis in human cancer cells, J CELL PHYS, 182(2), 2000, pp. 209-213

Authors: Davidson, NE Hahm, HA McCloskey, DE Woster, PM Casero, RA
Citation: Ne. Davidson et al., Clinical aspects of cell death in breast cancer: the polyamine pathway as a new target for treatment, ENDOCR-R CA, 6(1), 1999, pp. 69-73

Authors: Reilly, TP Macarthur, RD Farrough, MJ Crane, LR Woster, PM Svensson, CK
Citation: Tp. Reilly et al., Is hydroxylamine-induced cytotoxicity a valid marker for hypersensitivity reactions to sulfamethoxazole in human immunodeficiency virus-infected individuals?, J PHARM EXP, 291(3), 1999, pp. 1356-1364

Authors: Reilly, TP Woster, PM Svensson, CK
Citation: Tp. Reilly et al., Methemoglobin formation by hydroxylamine metabolites of sulfamethoxazole and dapsone: Implications for differences in adverse drug reactions, J PHARM EXP, 288(3), 1999, pp. 951-959

Authors: Webb, HK Wu, ZQ Sirisoma, N Ha, HC Casero, RA Woster, PM
Citation: Hk. Webb et al., 1-(N-alkylamino)-11-(N-ethylamino)-4,8-diazaundecanes: Simple synthetic polyamine analogues that differentially alter tubulin polymerization, J MED CHEM, 42(8), 1999, pp. 1415-1421

Authors: Edwards, DJ Fitzsimmons, ME Schuetz, EG Yasuda, K Ducharme, MP Warbasse, LH Woster, PM Schuetz, JD Watkins, P
Citation: Dj. Edwards et al., 6 ',7 '-Dihydroxybergamottin in grapefruit juice and Seville orange juice:Effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein, CLIN PHARM, 65(3), 1999, pp. 237-244
Risultati: 1-16 |